title: Monoclonal antibody JC1: new reagent for studying cell proliferation.
abstract: OBJECTIVE
  To characterise a newly developed mouse monoclonal antibody JC1 which recognises a nuclear antigen present in proliferating cells in normal tissues and neoplastic lesions, and which is absent in resting cells.
  
  
  METHODS
  The methodology was established using a representative range of frozen sections from normal tissues and from certain tumours which were immunostained with antibodies Ki67 and JC1. The molecular weight of the antigen recognised by JC1 was obtained by western blot analysis and this was compared with that of Ki67. IM-9 cell lysates containing Ki67 derived plasmids were also tested with JC1 antibody.
  
  
  RESULTS
  Biochemical investigation indicated that the antigen recognised by JC1 gives two molecular weight bands of 212 and 123 kilodaltons, which is distinct from the well characterised anti-proliferation monoclonal antibody Ki67 (395-345 kilodaltons). In addition recombinant Ki67 protein is not recognised by JC1. Immunohistological reactivity was seen in areas known to contain numerous proliferating cells such as lymphoid germinal centres, splenic white matter, cortical thymocytes and undifferentiated spermatogonia. In tumours many cells from adenocarcinomas, oat cell carcinomas, squamous cell carcinomas of lung, and seminomas were labelled by JC1 with a distribution and proportion similar to that seen with Ki67. In normal tissues the only apparent difference was in testis where JC1 stained a considerably greater number of cells than Ki67. In all cases studied the new antibody showed nuclear reactivity only. JC1 did not show any cytoplasmic crossreactivity with squamous cells as is frequently seen with Ki67.
  
  
  CONCLUSIONS
  Antibody JC1, which recognises a nuclear antigen present in proliferating cells, should provide a useful adjunct to Ki67 as a marker of proliferation especially in those cases such as squamous cell carcinomas where a Ki67 index cannot be determined.
authors.affiliation: Nuffield Department of Pathology, John Radcliffe Hospital, Oxford.
authors.forename: M C
authors.initials: MC
authors.lastname: Garrido
authors.forename: J L
authors.initials: JL
authors.lastname: Cordell
authors.forename: M H
authors.initials: MH
authors.lastname: Becker
authors.forename: G
authors.initials: G
authors.lastname: Key
authors.forename: J
authors.initials: J
authors.lastname: Gerdes
authors.forename: M
authors.initials: M
authors.lastname: Jones
authors.forename: K C
authors.initials: KC
authors.lastname: Gatter
authors.forename: D Y
authors.initials: DY
authors.lastname: Mason
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000941:Antigens / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000276:immunology; D015153:Blotting, Western; D002455:Cell Division / Q000276:immunology*; D002467:Cell Nucleus / Q000276:immunology*; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology; D008297:Male; D051379:Mice; D008970:Molecular Weight; D014066:Palatine Tonsil / Q000276:immunology; D013736:Testicular Neoplasms / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000941:Antigens; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor